New York is one of the most demanding states in the country for healthcare billing. For pulmonary and critical care practices operating in New York City, Long Island, Westchester, or upstate New York, the payer environment combines two of the most complex billing relationships in American medicine: Empire BlueCross BlueShield, one of the largest and most administratively intensive commercial payers in the Northeast, and New York Medicaid, a program of such scale and regulatory complexity that entire billing departments are dedicated exclusively to understanding its rules.
The denial patterns that emerge from these two payer relationships are not random. They follow predictable trajectories rooted in payer-specific policies, documentation requirements, and utilization management criteria that differ materially from national norms and from what practices in other states experience. Understanding those patterns — specifically for pulmonary and critical care services — is the foundation of a billing operation that consistently captures earned revenue rather than writing it off as the cost of doing business in New York.
This post examines the specific denial patterns that Empire BCBS and New York Medicaid generate for pulmonary practices, what drives them, and what billing workflows prevent them from recurring.
Empire BlueCross BlueShield: The New York Pulmonary Billing Landscape
Empire BlueCross BlueShield is the largest commercial insurer in New York State and one of the dominant payers for pulmonary practices in the New York City metro area, Long Island, and the Hudson Valley. As a licensee of the Blue Cross Blue Shield Association, Empire operates its own medical policies, utilization management programs, and prior authorization requirements that are distinct from other BCBS plans — including neighboring plans in New Jersey and Connecticut.
Empire also administers benefits for a large number of self-insured employer plans in New York under administrative services only (ASO) arrangements. These ASO plans may follow Empire’s standard medical policies or may have customized benefit designs that differ from Empire’s commercial products. A pulmonary procedure that is covered under Empire’s standard commercial plan may be subject to different authorization requirements or coverage criteria under an ASO plan — and the claim form does not always make the distinction clear.
What Empire Is Denying for Pulmonary Services
Empire applies prior authorization requirements to a broad range of pulmonary procedures. Bronchoscopy, endobronchial ultrasound (EBUS), navigational bronchoscopy, pulmonary rehabilitation, polysomnography, home sleep apnea testing, and certain pulmonary function test sequences all require authorization under Empire’s commercial plans. The authorization requirements are updated periodically through Empire’s medical policy bulletins, which practices are expected to monitor and incorporate into their authorization workflows.
The most consistent denial pattern for pulmonary services from Empire involves medical necessity documentation. Empire’s medical necessity criteria for pulmonary procedures are derived from evidence-based clinical guidelines but applied with a specificity that many practices’ standard clinical documentation does not reach. For pulmonary function testing, Empire expects documentation of the specific clinical question the testing is intended to answer, the patient’s relevant clinical history, and — for repeat testing — the clinical rationale for why prior results are insufficient.
For sleep diagnostics, Empire has adopted specific coverage criteria for home sleep apnea testing that require documented pre-test probability assessment. A note that documents a chief complaint of snoring and orders a home sleep study does not meet Empire’s criteria. The ordering provider’s documentation must reflect a clinical evaluation consistent with moderate to high pre-test probability of obstructive sleep apnea, including assessment of symptoms, body habitus, and comorbidities.
For biologic therapies used in severe asthma — a growing and high-revenue category for pulmonary practices — Empire requires step-therapy documentation, laboratory confirmation of relevant biomarkers (eosinophil counts, IgE levels, FeNO measurements depending on the biologic), and specialist attestation of severe uncontrolled asthma. Missing any element of this documentation package results in authorization denial, which delays patient access to therapy and creates revenue cycle disruption for the practice.
Empire’s Appeal Process and Why Most Pulmonary Appeals Fail
Empire has a formal appeals process that allows practices to contest denied claims through first-level internal appeals, second-level internal appeals, and external independent review. For pulmonary practices in New York, the external review process is governed by New York State Department of Financial Services regulations, which provide stronger patient and provider protections than most other states.
Despite these protections, the majority of pulmonary practice appeals against Empire denials fail at the first level — not because the services were inappropriate, but because the appeals are submitted without the documentation that addresses Empire’s specific denial rationale. An appeal that restates the clinical appropriateness of the procedure in general terms, without directly addressing the medical necessity criteria Empire cited in the denial, will not succeed.
Successful Empire appeals for pulmonary services cite Empire’s own clinical policy bulletins, reference the specific criteria the service meets, and include supporting documentation that was not present in the original claim submission. Practices that treat the appeal as a letter-writing exercise rather than a clinical-documentation exercise consistently underperform on appeal recovery rates.
New York Medicaid: The Most Complex Billing Environment in the State
New York Medicaid is the largest Medicaid program in the United States by expenditure and among the most administratively complex for providers. For pulmonary practices that serve New York’s Medicaid population — which is substantial, particularly in New York City, the Bronx, Brooklyn, and upstate urban centers — the billing environment involves layers of regulatory requirements, managed care plan variations, and documentation standards that have no parallel in commercial insurance billing.
Medicaid Managed Care: The Structural Foundation
The majority of New York Medicaid beneficiaries are enrolled in Medicaid managed care plans rather than fee-for-service Medicaid. The major Medicaid managed care organizations operating in New York include MetroPlus Health Plan, Healthfirst, Fidelis Care, Molina Healthcare of New York, and WellCare of New York, among others. Each operates under a contract with the New York State Department of Health but maintains its own prior authorization requirements, claims submission rules, and medical necessity criteria.
The structural billing consequence is identical to what Massachusetts practices face with MassHealth MCOs: claiming submitted to fee-for-service Medicaid for a patient enrolled in a Medicaid managed care plan will be denied. The patient is not ineligible — the claim went to the wrong entity. For New York City pulmonary practices with high Medicaid volume, this routing error is among the most common and most preventable sources of claim denials.
New York’s Medicaid eligibility verification system (ePACES) allows providers to confirm both Medicaid eligibility and managed care plan enrollment simultaneously. Practices that do not use ePACES for eligibility verification at scheduling — or that rely on patient-reported insurance information — will encounter MCO routing errors with regularity.
What New York Medicaid Is Denying for Pulmonary Services
New York Medicaid and its managed care plans deny pulmonary claims across several consistent categories. Prior authorization non-compliance is the leading driver — pulmonary procedures including bronchoscopy, sleep diagnostics, pulmonary rehabilitation, and certain diagnostic testing sequences require authorization under most Medicaid managed care plans, and the authorization requirements vary by plan.
Timely filing is a significant issue for New York Medicaid billing. Fee-for-service Medicaid has a 90-day timely filing requirement from the date of service for most claims. Medicaid managed care plans may have different timely filing windows — some as short as 60 days. For practices with high claim volumes and billing staff turnover, Medicaid claims are disproportionately at risk for timely filing denials because they require more administrative handling and are more likely to be set aside during periods of billing department stress.
Referral and authorization chain integrity is another consistent denial driver for New York Medicaid managed care. Many Medicaid managed care plans in New York require that specialist visits be preceded by a primary care referral. When a patient self-refers to a pulmonologist or when the referral documentation is not on file at the time of claim submission, the claim denies for missing referral. This is particularly common in New York City, where patients frequently navigate the healthcare system independently and referral documentation chains are not always maintained with the specialist’s practice.
New York Medicaid Documentation Requirements for Pulmonary Services
New York Medicaid has specific documentation requirements for pulmonary services that differ from both commercial payer standards and Medicare requirements. For pulmonary rehabilitation, New York Medicaid requires a physician order that documents the diagnosis, the frequency and duration of the prescribed program, and the expected outcomes. Progress notes must document the patient’s attendance, clinical progress, and continued medical necessity at defined intervals.
For home oxygen and respiratory equipment ordered for Medicaid patients, New York Medicaid requires a detailed written order and, for certain equipment categories, a Certificate of Medical Necessity completed by the ordering physician. Incomplete CMNs are a consistent source of DME-related claim denials that reflect on the ordering pulmonologist’s documentation, even though the DME supplier submits the claim.
For sleep diagnostic services, New York Medicaid’s covered service criteria require documentation of clinical evaluation consistent with sleep-disordered breathing, including symptom assessment and relevant comorbidity documentation. HSAT coverage under New York Medicaid managed care plans varies by plan — some plans cover HSAT as a less expensive alternative to in-lab PSG; others require in-lab testing for certain patient populations. Billing HSAT for a patient whose plan requires PSG will result in denial regardless of the clinical appropriateness of the home study.
The New York City Market: Specific Billing Challenges for Urban Pulmonary Practices
New York City pulmonary practices face a set of billing challenges that are specific to the urban market and distinct from what practices in Long Island, Westchester, or upstate New York encounter. The concentration of Medicaid and dual-eligible patients in the five boroughs, the prevalence of hospital-based pulmonary practices affiliated with major academic medical centers, and the administrative complexity of billing across multiple payers with high volumes creates a billing environment where process gaps have outsized financial consequences.
Dual-Eligible Patient Billing: Medicare and Medicaid Coordination
New York City has a large population of dual-eligible patients — individuals who are enrolled in both Medicare and Medicaid. For pulmonary practices, dual-eligible patients present a billing coordination challenge: Medicare is the primary payer and Medicaid is the secondary payer, covering cost-sharing obligations that Medicare does not pay. The claim must be submitted to Medicare first, and the Medicare remittance must be used to generate the Medicaid secondary claim.
Many dual-eligible patients in New York are enrolled in Medicaid managed care plans that coordinate with Medicare Advantage plans under the Fully Integrated Dual Advantage (FIDA) program or the Dual Eligible Special Needs Plan (D-SNP) structure. Billing for FIDA and D-SNP patients requires knowing the specific plan structure, the correct primary payer, and the crossover claim process — which differs from standard Medicare-Medicaid coordination.
Practices that do not have a documented dual-eligible billing protocol will routinely misbill these patients — submitting to Medicaid as primary when Medicare is primary, or failing to submit the Medicaid secondary claim at all. Both errors result in revenue loss: the first in a denial, the second in uncollected cost-sharing that Medicaid would have covered.
Hospital-Based Practice Billing: The Professional Component Challenge
New York City’s concentration of academic medical centers means that many pulmonary and critical care physicians practice in hospital-based settings where the facility bills separately for the technical component of services. For these practices, correct modifier usage — particularly the 26 modifier for professional component billing in a facility setting — is essential for accurate claim submission and correct reimbursement.
A consistent finding in AR reviews of New York City hospital-based pulmonary practices is incorrect site-of-service coding. Claims submitted with a place of service code that does not match the actual setting where the service was provided — for example, billing with office place of service for a service rendered in a hospital outpatient department — result in reimbursement at the incorrect rate and, in some cases, outright denial. Empire BCBS and New York Medicaid both audit place-of-service accuracy and have recoupment programs for systematic site-of-service errors.
For pulmonary practices that operate in both office and hospital-based settings, the place-of-service coding and modifier selection must be specific to each service location — not defaulted from a practice-wide billing template that does not account for setting variation.
Building an Empire BCBS and New York Medicaid-Ready Billing Workflow
The denial patterns described in this post are preventable with the right billing workflows in place. A New York pulmonary practice ready to bill Empire BCBS and New York Medicaid effectively needs the following elements:
- ePACES-based eligibility verification at scheduling. Every Medicaid patient must have MCO enrollment confirmed through ePACES before the appointment, with the specific managed care plan documented in the scheduling record.
- Empire and Medicaid MCO-specific authorization matrices. A current reference document by payer and procedure that authorization staff consult at scheduling, updated when payer policy bulletins are issued.
- Medical necessity documentation templates for high-denial procedures. Templates for PFTs, sleep diagnostics, bronchoscopy, pulmonary rehabilitation, and biologics that are built around Empire’s and Medicaid’s specific criteria — not general clinical documentation standards.
- Dual-eligible billing protocol. A documented process for identifying dual-eligible patients, confirming FIDA or D-SNP enrollment, and managing the Medicare primary / Medicaid secondary claim submission sequence.
- Site-of-service and modifier verification at charge entry. For practices operating in multiple settings, a charge entry verification step that confirms place-of-service code and modifier selection match the actual service location for each claim.
- Appeal strategy built around payer-specific criteria. Empire and Medicaid appeals that cite the payer’s own clinical policy, address the specific denial rationale, and include documentation that fills the gap the payer identified.
The Cost of Getting It Wrong in New York
Revenue leakage from Empire BCBS and New York Medicaid denials is not evenly distributed across procedure types. High-value procedures — bronchoscopy, EBUS, biologic prior authorizations, critical care services — carry the highest per-claim revenue risk when they deny. High-volume procedures — office visits, pulmonary function testing, sleep study interpretations — carry the highest aggregate revenue risk because denials multiply across large claim volumes.
For a New York City pulmonary practice with significant Empire BCBS and Medicaid volume, a systematic denial pattern in either payer relationship can represent $100,000 to $300,000 in annual revenue loss. The practices that identify and address these patterns through payer-specific billing workflows recover that revenue prospectively. The practices that treat each denial as an individual event — rather than a symptom of a systemic gap — continue to lose it.
New York’s healthcare market is too competitive and too expensive to absorb preventable revenue loss. Practices that cannot capture what they earn will eventually face the pressure to reduce services, reduce staff, or reduce access — outcomes that undermine the clinical mission they were built to serve.
How PulmoCare RCM Helps New York Pulmonary Practices
PulmoCare RCM specializes in pulmonary and critical care billing for practices in New York. Our billing workflows are built around Empire BCBS and New York Medicaid requirements specifically — including Medicaid managed care plan variations, dual-eligible billing protocols, and hospital-based practice modifier and site-of-service requirements.
We start with an AR review that identifies your Empire and Medicaid denial patterns by procedure and by denial category — surfacing the systemic gaps that are driving your write-offs and quantifying the revenue impact.
If your New York pulmonary practice is experiencing Empire BCBS or Medicaid denial patterns and you are not certain your current billing workflow is addressing their root cause, reach out to PulmoCare RCM for a complimentary consultation.